About NeoTract, Inc. NeoTract, Inc. is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. NeoTract is a very high achieving organization that operates under a set of standards that promote innovation, collaboration and integrity at all times. Customer focused, NeoTract employs a sales force of urology consultants, who strive to partner with our customers to improve their practices by offering access to superior state of the art healthcare.... View Article
Location: United States, California, Pleasanton
Total raised: $23.7M
Investors 3
| Date | Name | Website |
| 06.07.2021 | New Enterp... | nea.com |
| - | CRG | crglp.com |
| - | Questa Cap... | questacapi... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 30.07.2009 | - | $23.7M | - |
Mentions in press and media 6
| Date | Title | Description |
| 09.02.2018 | Stanford spin-out Zenflow raises $31M to join the megamarket for enlarged prostate | In a phone interview, Damiano said the startup “threw out a broad net” for funding and between 2015 and 2017, it hauled in $5.2 million in seed funding, mostly from angel investors. Along the way, it was supported by the StartX accelerator ... |
| 08.05.2015 | Medtech execs: Thinking about reimbursement early is key to a successful launch | At a time when the regulatory barriers put up by the Food and Drug Administration seem to be easing a bit, Medtech companies are still facing challenges bringing new products to market, a panel at the Medtech Investing Conference 2015 in Mi... |
| 05.09.2012 | Startup targeting enlarged prostate patients believes it can change the lives of men globally | Founder and CEO Michael Todd won’t reveal too many details about the procedure and the device except to say that it uses the transrectal approach to the prostate as opposed to a transurethral approach. Current surgical procedures also emplo... |
| 30.07.2009 | Neotract raises $23.7M to treat urological and gynecological disorders | Neotract, maker of devices used to treat urological and gynecological disorders, has raised $23.73 million of a targeted $25.2 million second round of funding according to PE Hub. Based in Pleasanton, Calif., the company was backed in this ... |
| - | Stanford spin-out Zenflow raises $31M to join the megamarket for enlarged prostate | A San Francisco, California-based medical device startup, Zenflow, has announced a $31.4 million Series A financing round to further its minimally-invasive approach to treating benign prostatic hyperplasia (BPH) or enlarged prostate. The co... |
| - | Startup targeting enlarged prostate patients believes it can change the lives of men globally | A stealth mode Simi Valley, California startup wants to disrupt the field of how benign prostatic hyperplasia (BPH) is treated. The traditional methods include drug therapy and when that fails, surgical procedures involving the urethra and ... |